Biotechnology

Biotechnology Breaking News Market News Technology The Market Buzz

Breaking News: Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea

financial buzz04/09/2020

28

Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) (CSE: AGN) (FRANKFURT: AGW) a clinical stage pharmaceutical development company is pleased to announce that a regulatory submission has been made to the Ministry of...

Biotechnology Breaking News Healthcare Market News Technology The Market Buzz

Breaking News: Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study

financial buzz04/01/2020

93

Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) (CSE: AGN) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has submitted for ethics approval in...

Biotechnology Breaking News Buzz on The Street Market News Technology The Buzz TV The Market Buzz Top Videos Uncategorized Video

“Buzz on the Street” Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Program for COVID-19

financial buzz03/24/2020

46

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19” Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) (CSE:...

Biotechnology Breaking News Market News Technology The Market Buzz

Breaking News: Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19

financial buzz03/24/2020

124

Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to provide an overview of its multiple recent activities surrounding...

Biotechnology Breaking News Buzz on The Street Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Algernon (OTCQB: AGNPF) (CSE: AGN) to Manufacture Ifenprodil for COVID-19

financial buzz03/23/2020

43

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials” Algernon Pharmaceuticals...

Biotechnology Breaking News Market News Technology The Market Buzz

Breaking News: Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials

financial buzz03/23/2020

148

Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company announces that it has awarded the contract to manufacture the active pharmaceutical...

Biotechnology Breaking News Buzz on The Street Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Imagin Medical (OTCQB: IMEXF) (CSE: IME) Imaging for Bladder Cancer

financial buzz03/10/2020

1162

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Imagin Medical Reports Physician Feedback On i/Blue(TM) Imaging System For Bladder Cancer Visualization” Imagin Medical (CSE:...

Biotechnology Breaking News Market News Technology The Market Buzz

Breaking News: Imagin Medical Reports Physician Feedback On i/Blue(TM) Imaging System For Bladder Cancer Visualization

financial buzz03/10/2020

1149

Imagin Medical (CSE: IME)(OTCQB: IMEXF) (FRA: DPD2) (“Imagin” or the “Company”) today reported on-going market research feedback on the i/Blue™ Imaging System which enables simultaneous viewing of white and...

Behind the Buzz Biotechnology Interviews Technology

“Behind the Buzz” Show: Field Trip Ventures Inc. Co-Founder Ronan Levy

financial buzz10/29/201910/29/2019

149

FinancialBuzz.ca’s latest Behind the Buzz Show: Featuring Field Trip Ventures Inc. Co-Founder Ronan Levy Field Trip Ventures Inc.’s mission is to heal the sick, and better the well, through...

Biotechnology Healthcare Investing News Technology

Pfizer Stock Gains on 2019 Guidance Boost

Haley Alber10/29/201910/29/2019

101

Shares of pharmaceutical giant Pfizer, Inc. (NYSE: PFE) are up about 3% on Tuesday after the company posted stronger-than-expected third quarter earnings and boosted its full-year revenue guidance. The...

Breaking News: Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea

Breaking News: Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study

“Buzz on the Street” Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Program for COVID-19

Breaking News: Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19

“Buzz on the Street” Show: Algernon (OTCQB: AGNPF) (CSE: AGN) to Manufacture Ifenprodil for COVID-19

Breaking News: Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials

“Buzz on the Street” Show: Imagin Medical (OTCQB: IMEXF) (CSE: IME) Imaging for Bladder Cancer

Breaking News: Imagin Medical Reports Physician Feedback On i/Blue(TM) Imaging System For Bladder Cancer Visualization

“Behind the Buzz” Show: Field Trip Ventures Inc. Co-Founder Ronan Levy

Pfizer Stock Gains on 2019 Guidance Boost

Entertainment One and Alibaba Pictures Announce Joint Production to Bring Peppa Pig to Theaters in China

Environmental Class Action Plaintiffs Achieve Major Victory in Federal Appeals Court

Healthcare Administrative Technology Association (HATA) Adopts Position on Practice Management Systems as Covered Entities

Ottawa Prepares to Invoke Never-Used Emergencies Act

Breaking News: Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea

Starbucks Expects Second-Quarter Earnings Loss

About Us

Instagram

Latest Tweets